首页> 外文会议>Annual Meeting of the National Mastitis Council >EFFECT OF THE SELECTIVE TREATMENT OF CLINICAL MASTITIS BASED IN ON- FARM CULTURE RESULTS ON THE RISK TO RECEIVE SECONDARY THERAPY, DAYS TO CLINICAL CURE AND DAYS OUT OF THE TANK
【24h】

EFFECT OF THE SELECTIVE TREATMENT OF CLINICAL MASTITIS BASED IN ON- FARM CULTURE RESULTS ON THE RISK TO RECEIVE SECONDARY THERAPY, DAYS TO CLINICAL CURE AND DAYS OUT OF THE TANK

机译:基于农业培养的临床乳腺炎的选择性治疗结果对接受二次治疗的风险,临床治疗和坦克的几天

获取原文

摘要

Mastitis remains the most costly infectious disease, and the most frequent cause of antibacterial use on commercial dairy farms. As such, research should continue on the development and validation of new management tools that will help reduce the health and economic impact of this disease, while at the same time promoting the judicious and strategic use of antimicrobials on dairy farms. Lago et al. (2008) reported that the adoption of an on-farm culture system to guide strategic treatment decisions resulted in a significant reduction in antibiotic use, but no significant decrease in bacteriological cure risk for mild or moderate cases of clinical mastitis (CM). The objective of this abstract is to describe the effect of the aforementioned treatmentprogram on the risk to receive secondary therapy, days to clinical cure and days out of the tank.
机译:乳腺炎仍然是最昂贵的传染病,以及商业乳制品农场抗菌用途的最常见原因。因此,研究应继续开发和验证新的管理工具,这将有助于降低这种疾病的健康和经济影响,同时促进乳制品农场的明智和战略使用抗微生物。 Lago等人。 (2008年)报告说,通过一个农场文化制度来指导战略治疗决策导致抗生素使用的显着降低,但临床乳腺炎(CM)的轻微或中度病例没有显着降低。本摘要的目的是描述上述治疗方法对接受二次治疗的风险的影响,临床治疗的天数和坦克的几天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号